Maxell Pharma Private Limited, a active private limited company, was established on 16 April 2010 in Sriperumbudur, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24297TN2010PTC075380. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.23 M.
It upholds a compliant status. Its leadership includes Madhuram Senthil Kumar (Director), Madhuram Udhaya Chander (Director), Takai Ali Bayas Ali (Director). Past directors included Takai Ali Bayas Ali, Shankar Subramanian. It holds ₹4.61 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 63,64,70 & 71 Second Floor, Vgn Highness, Rajendravarma Street, Srinivasapuram, Sriperumbudur, Tamil Nadu, 600056.
U24297TN2010PTC075380
075380
16 April 2010
₹5.00 M
₹4.23 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Maxell Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhuram Senthil Kumar | Director | 21 Apr 2022 | Current |
| Madhuram Udhaya Chander | Director | 16 Apr 2010 | Current |
| Takai Ali Bayas Ali | Director | 16 Apr 2010 | Current |
| Gnanasekaran Satheeshkumar | Director | 16 Apr 2010 | Current |
| Shankar Subramanian | Managing Director | 16 Apr 2010 | Current |
| Saravanan | Director | 16 Apr 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 28 Jan 2023 | Past |
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxell Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.27% decrease. The company also saw a substantial fall in profitability, with a 77.07% decrease in profit. The company's net worth moved up by a moderate rise of 5.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Maxell Pharma had a public holding of 47.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹46,145,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2023 | City Union Bank Limited | ₹2.79 Cr | Open |
| 24 Dec 2021 | Others | ₹1.50 Cr | Open |
| 29 Apr 2021 | Others | ₹3.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maxell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maxell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxell Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Maxell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with City Union Bank Limited of Rs. 27.95 M registered on 02 Mar 2023 with Charge ID 100712811 was modified on 06 Sep 2024. was recorded as a recent event.
Maxell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on A charge with City Union Bank Limited amounted to Rs. 27.95 M with Charge ID 100712811 was registered on 02 Mar 2023. was documented.
Madhuram Senthil Kumar was appointed as a Director was appointed as a Director on 21 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 15.00 M with Charge ID 100517192 was registered on 24 Dec 2021. was documented.
The CIN of Maxell Pharma Private Limited is U24297TN2010PTC075380.
Maxell Pharma Private Limited is headquartered at No. 63,64,70 & 71 Second Floor, Vgn Highness, Rajendravarma Street, Srinivasapuram, Sriperumbudur, Tamil Nadu, 600056.
Maxell Pharma Private Limited was incorporated on 16 April 2010.
The current directors of Maxell Pharma Private Limited are
The primary industry of Maxell Pharma Private Limited is Trade.
Maxell Pharma Private Limited is unlisted.
The authorized capital of Maxell Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹4.23 M.
The compliance status of Maxell Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX